Medical Condition News

RSS

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

Research paper evaluates the mental health impacts of the first COVID-19 wave on U.K. residents, revealing heightened psychological distress particularly among younger people, women, and minority groups. Factors such as financial stress, loneliness, and household density were found to significantly influence the severity of mental health decline during the pandemic.

23 Oct 2023

New insights into why obesity puts individuals at risk for severe influenza

The mechanisms underpinning severe cases of influenza among the obese population.

23 Oct 2023

Groundbreaking study reveals most effective adjunctive drug for Parkinson's disease

The efficacy, tolerability, and safety of various anti-Parkinson's drugs.

23 Oct 2023

Shedding light on the future of cognitive health in a graying world

Age-related cognitive decline and changes in the brain.

23 Oct 2023

Metacognition and the pandemic: how our beliefs influence our choices

The ability to self-reflect upon one's beliefs and behavior, during the coronavirus disease 2019 (COVID-19) pandemic.

23 Oct 2023

Can strawberries mitigate Alzheimer's risk? Recent study suggests a possibility

Whether strawberry supplementation mitigates the risk for late-life dementia.

23 Oct 2023

The transmission dynamics of SARS-CoV-2 among healthcare workers

The transmission of SARS-CoV-2 in hospitals and its impact on the dynamics of the COVID-19 pandemic.

23 Oct 2023

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer.

22 Oct 2023

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).

22 Oct 2023

Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

22 Oct 2023

Ketamine's long-lasting antidepressant effects unveiled in new study

Persistent blocking of NMDAR and burst-type firing by lateral habenula (LHb) neurons may offer a basis for the long-lasting antidepressant effects of ketamine.

22 Oct 2023

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statistically significant improvement in recurrence-free survival compared to patients getting placebo after surgery.

22 Oct 2023

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

In a study published in Scientific Reports, researchers engineer long-lasting GLP-1 receptor agonists by fusing GLP-1 with an HSA-binding protein. These chimeric molecules show promise for the treatment of type 2 diabetes due to their stability, functionality, and high affinity for the GLP-1 receptor and human serum albumin.

22 Oct 2023

Nature videos boost adolescent mental health: Study shows reduced stress and improved mood

Brief nature video exposure improved stress, mood, and relaxation, highlighting the potential of nature-based interventions for adolescent mental health.

22 Oct 2023

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.

22 Oct 2023

Hormone levels tied to metabolic health in obesity

Researchers investigate the relationship between obesity types and serum leptin (LEP) and adiponectin (ADP) levels, shedding light on metabolic differences in various obesity phenotypes. Their findings highlight correlations between adipokines, glucose utilization, lipid metabolism, and obesity-related metabolic disorders.

22 Oct 2023

Does adding sugar to coffee and tea impact your lifespan? 32-year study reveals surprising results

A study on Danish men found that adding sugar to tea and coffee did not significantly impact all-cause, cancer-related, or cardiovascular mortality risk over a 32-year follow-up period, challenging previous sugar consumption research's findings on adverse health outcomes.

22 Oct 2023

Can Beta-carotene boost cognitive health? Study reveals promising insights

A systematic review explores the potential of β-carotene in enhancing cognitive function, revealing its potential benefits and the importance of dietary interventions for cognitive health.

22 Oct 2023

Anxiety's impact: Young adults face cognitive and cardiovascular challenges

In a recent study published in the journal PLOS ONE, scientists investigated the links between anxiety, depression, endothelial function, and cognitive abilities in young adults, revealing that anxiety independently correlated with both poor cognitive performance and impaired endothelial function.

22 Oct 2023

Decoding schizophrenia: insights and impacts from genetic discoveries

A recent study in Molecular Psychiatry delves into the genetic architecture of schizophrenia, uncovering insights into common and rare genetic variants, treatment resistance, and the evolutionary paradox of the disorder. This research highlights the complex nature of schizophrenia and the need for a transdiagnostic approach to psychiatric research.

22 Oct 2023

Medical Condition News

Lockdown blues: Study reveals stark impact of COVID-19 on mental health in the UK

New insights into why obesity puts individuals at risk for severe influenza

Groundbreaking study reveals most effective adjunctive drug for Parkinson's disease

Shedding light on the future of cognitive health in a graying world

Metacognition and the pandemic: how our beliefs influence our choices

Can strawberries mitigate Alzheimer's risk? Recent study suggests a possibility

The transmission dynamics of SARS-CoV-2 among healthcare workers

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Ketamine's long-lasting antidepressant effects unveiled in new study

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

Nature videos boost adolescent mental health: Study shows reduced stress and improved mood

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

Hormone levels tied to metabolic health in obesity

Does adding sugar to coffee and tea impact your lifespan? 32-year study reveals surprising results

Can Beta-carotene boost cognitive health? Study reveals promising insights

Anxiety's impact: Young adults face cognitive and cardiovascular challenges

Decoding schizophrenia: insights and impacts from genetic discoveries

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News